Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded down 0.1% during trading on Wednesday. The stock traded as low as $0.6925 and last traded at $0.8853. Approximately 2,105 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 9,053 shares. The stock had previously closed at $0.8860.
Peak Pharmaceuticals Stock Down 0.1%
The company’s fifty day moving average price is $0.99 and its two-hundred day moving average price is $1.01.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
